ITGA2 and chronic myelogenous leukemia, BCR-ABL1 positive: In the current study, we aimed to clarify the role of integrin-mediated imatinib resistance in CML by inhibiting ITGA2 using E7820 and analyzing its effects on cell proliferation and apoptosis pathway induction in CML cells.